This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
THE SPRINGTIME PARTNERING EVENT
March 17–19, 2025 | Milan, ItalyMarch 25–26, 2025 | Digital Partnering

Konstantina Katcheves
SVP, Global Business Development and Acquisitions at Teva Pharmaceuticals
Speaker

Profile

Konstantina Katcheves, Senior Vice President (SVP), Global Business Development for Innovative Medicines, Teva Pharmaceuticals.

A seasoned dealmaker and enterprise leader, Konstantina brings more than 20 years of life sciences and pharmaceuticals experience with demonstrated success in international leadership, business strategy, intellectual property, and negotiation of international partnerships. At Teva, Konstantina is building and developing an innovative medicines business development team and strategy to help drive Teva’s Pivot to Growth. Her team focuses on partnerships in neuroscience, immunology and rare disease leveraging Teva’s development capabilities and commercial strength across the global to deliver more innovative medicines i.

Prior to joining Teva, Konstantina was Senior Vice President for business development at Bristol Myers Squibb (BMS) and also interim head of Enterprise Strategy & BD leading BMS through a historic quarter of major and transformative transactions. Prior to that, she led BMS in collaborations at various stages across therapeutic areas, including early discovery partnerships, digital innovation, precision medicine and cell and gene therapy technologies, and regional business development for Japan and China.

As an leader in life sciences, Konstantina has a personal and professional interest in supporting women’s health initiatives and women’s success as a mentor to other females in science and healthcare

Konstantina has held leadership positions as both a lawyer and a BD leader, including Vice President of Intellectual Property & Licensing at Agilent Technologies and Vice President of Global Intellectual Property, Licensing and Strategic Alliance at Lonza.

Konstantina holds a Bachelor of Science in cell biology and biochemistry from the University of California at San Diego, a Juris Doctor from the University of Oklahoma College of Law, and a Master of Science in Biotechnology from Johns Hopkins University. Her personal interests include spending time in Greece and enjoying water activities from boating to swimming. Connect with Konstantina on LinkedIn.


Agenda Sessions

  • Deals in vogue: Navigating M&A and business development in a shifting global landscape

    11:30